Clinical Trials
Senhwa's Silmitasertib Receives US FDA Fast Track Designation
Senhwa Biosciences, Inc., a drug development company focused on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, today ann...
August 19, 2021 | News
Terumo Blood and Cell Technologies and PhotonPharma Inc. announce collaboration to develop a novel cancer immunotherapy
Terumo Blood and Cell Technologies (Terumo), a medical device company specializing in a portfolio of technology, software and services for blood...
August 12, 2021 | News
New Zealand approved YishengBio COVID-19 vaccine trials
YishengBio is a biopharmaceutical company focusing on discovery, development, manufacturing and commercialization of new generations of vaccines and therap...
August 10, 2021 | News
Clarivate Acquires Bioinfogate
Expanding and integrating drug toxicity data and translational safety intelligence from OFF-X into all aspects of the life science cycle, allowing customer...
August 05, 2021 | News
Insilico ,Westlake to jointly develop innovative small-molecule drugs for COVID19
The cooperation will be based on the anti-COVID-19 drug R&D project by Westlake Pharma, which aims to develop broad-spectrum small molecule inhibitor d...
August 03, 2021 | News
Bharat Biotech’s ROTAVAC 5D® Receives WHO Prequalification
Prequalification will fast-track procurement and global access of ROTAVAC 5D® · &nbs...
August 02, 2021 | News
BIOKANGTAI COVID-19 Vaccine Approved for Phase III Clinical Trial in the Philippines
Earlier, BIOKANGTAI has already been approved by the Vaccine Expert Panel (VEP) of the Philippine Department of Science and Technology (DOST) on June ...
August 02, 2021 | News
Clarity commences theranostic prostate cancer trial
Clarity's Executive Chairman, Dr Alan Taylor, commented, "The prostate cancer market is a key focus for Clarity and we are very pleased to commence th...
July 29, 2021 | News
LISCure, the first Korean biotech company receiving equity investment from Mayo Clinic
LISCure Biosciences, Inc. ("LISCure") has entered into a know-how license and development collaboration agreement, and stock purchase agreement with Mayo C...
July 26, 2021 | News
Pfizer & BioNTech to manufacture and distribute covid-19 vaccine doses within Africa
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the signing of a letter of intent with The Biovac Institute (Pty) Ltd, known as &ldq...
July 22, 2021 | News
Novotech Joins (DTRA) to Accelerate Clinical Trials
The "Decentralized Trials & Research Alliance(DTRA)" ( https://www.dtra.org/ ), which was launched in December, 2020, is uniting in...
July 21, 2021 | News
Thermo Fisher Scientific Expands Hematology Oncology NGS Portfolio
Thermo Fisher Scientific today announced a new suite of Ion Torrent Oncomine immune repertoire assays designed to detect potentially malignant cl...
July 20, 2021 | News
Aridis Pharmaceuticals COVID mAb AR-712 Neutralizes SARS-CoV-2 Delta Variant
Aridis Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threaten...
July 13, 2021 | News
I-Mab Expands Next Generation Novel Oncology Therapeutics
I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel bio...
July 10, 2021 | News
Most Read
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
